Merck files Bio-Techne deal in Cyprus
MLex Summary: German lifesciences company Merck has notified the Cyprus competition authority of its plans to acquire US biotechnology company Bio-Techne. The €10 billion deal, which received unconditional approval in Germany...To view the full article, register now.
Already a subscriber? Click here to view full article